通过调节YAP1核转位,COPB2促进肝细胞癌的进展
Biao Wu1, Xianlin Guo2, Zhishi Wu1
1Department of General Surgery, Changhai Hospital, Second (Navy) Military Medical University, Shanghai, 200433, China.
协同分子蛋白质复合体子单元β2 (COPB2) 和Yes相关蛋白1 (YAP1) 影响肝细胞癌 (HCC) 药物敏感性. 向COPB2/YAP1可能为HCC患者提供新的精确治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 是-关联蛋白1 (YAP1) 是肝细胞癌 (HCC) 的已知瘤基因.
- 在HCC中,协同体蛋白质复合体子单元β2 (COPB2) 的作用和机制尚未完全理解.
- 研究COPB2和YAP1之间的相互作用对于理解HCC进展至关重要.
研究的目的:
- 研究COPB2和YAP1在HCC进展中的作用.
- 阐明COPB2在调节YAP1.1中的潜在机制.
- 评估COPB2和YAP1在HCC中的预后价值和治疗影响.
主要方法:
- 使用数据库搜索和免疫组织化学分析HCC组织中的COPB2和YAP1表达.
- 建立基于COPB2和YAP1表达的预后模型 (名图,人工神经网络).
- 在体外测试包括细胞增殖,迁移,入侵,免疫光和西斑,以探索机制.
主要成果:
- 结合COPB2和YAP1表达是HCC患者的独立预后因素.
- 高COPB2和YAP1表达可能会降低跨动脉化血栓治疗的疗效.
- COPB2调节YAP1的核转位,影响HCC细胞对西斯 (DDP) 的敏感性.
结论:
- COPB2/YAP1轴影响HCC细胞对DDP的药物敏感性.
- 针对COPB2/YAP1通路提供了一个潜在的策略,用于HCC的精密处理.
更多相关视频
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
相关概念视频
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Nuclear Protein Sorting
Induced Pluripotent Stem Cells
Somatic...
